Education Library

Alexandra Lansky, MD, discusses a propensity-adjusted population-based analysis of Impella in patients undergoing high-risk PCI from a large-scale claims dataset. 

Ole Helgestad, PhD, discusses an automated variable selection method for predicting 30-day mortality in patients with AMICS receiving acute PCI. 

Cindy Grines, MD, presents data and clinical insights regarding complete revascularization and which patients might benefit from it.

Manreet Kanwar, MD, discusses the topic of heart recovery: How do we define it? How do we achieve it?

Gregg Stone, MD, reviews available data—from PROTECT II through PROTECT IV—for use of mechanical circulatory support during high-risk PCI.

Rajiv Tayal, MD, reviews best practices for large-bore access in this virtual fellows course.

A. Reshad Garan, MD, discusses the importance of determining etiology and predicting risk in patients with acute decompensated heart failure-related cardiogenic shock.

Benedikt Schrage, MD, discusses his paper examining how enrollment criteria in RCTs apply to the real-world cardiogenic shock patient population.

Babar Basir, DO, presents the National Cardiogenic Shock Initiative (NCSI) protocol for managing acute myocardial infarction cardiogenic shock (AMICS) at the 2021 HFSA scientific meeting.

This live case from Kate Kearney, MD and William Lombardi, MD, highlights Impella-supported complex PCI and complete revascularization in a patient with severe LV dysfunction.

Timothy Smith, MD, discusses the importance of the cardiovascular ICU and device management for patients with cardiogenic shock supported with the Impella® heart pump.

This Impella skills video demonstrates the mattress suture technique used during insertion of the Impella RP® heart pump.

This Impella skills video demonstrates how to change the femoral access site dressing in the ICU.

View an animation depicting the primary steps for anterior direct insertion of Impella 5.5 with SmartAssist.

This FAQ addresses thrombus formation and anticoagulation for blood-contacting medical devices, such as the Impella® heart pump.